Related Experiment Video
Updated: Jan 7, 2026
09:17
Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
762
Innovative Therapeutic Strategies for Chronic Ulcer Healing.
Paraskevi Mylona1, Konstantinos Tsoumakas2, Theodoros Mariolis-Sapsakos2
1Air Force Medical Training Center, 251 Air Force General Hospital, Athens, Greece.
Advances in Experimental Medicine and Biology
|January 1, 2026
Summary
This study explored how ascorbic acid, arginine, silver sulfadiazine, and colloidal silver impact chronic ulcer healing. These agents show promise in accelerating wound closure and improving skin integrity in patients.
Area of Science:
- Biomedical Science
- Dermatology
- Wound Healing Research
Background:
- Chronic ulcers pose significant challenges to patient quality of life and healthcare systems.
- Developing innovative therapies for enhanced tissue regeneration and accelerated wound closure is crucial.
Purpose of the Study:
- To investigate the effects of ascorbic acid, arginine, silver sulfadiazine, and colloidal silver on chronic ulcer healing.
- To elucidate the role of these agents in restoring skin integrity and promoting epithelialization.
Main Methods:
- A clinical study involving 106 patients divided into intervention and control groups.
- Systematic monitoring of key clinical healing markers for up to 75 days.
Main Results:
- The study provides insights into the efficacy of the investigated agents in modulating cellular repair.
- Findings suggest these compounds promote faster epithelialization and enhance skin integrity.
Conclusions:
- Ascorbic acid, arginine, silver sulfadiazine, and colloidal silver demonstrate potential in chronic wound management.
- Integrating these bioactive agents may improve healing rates and patient outcomes.
Keywords:
ArginineChronic ulcersEpithelializationOxidative stressProtease inhibitorsVitamin CWound healingZincMore Related Videos
Related Concept Videos
01:26Peptic Ulcer Disease IV: Management
397
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
397
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.3K
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.0K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.0K
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
786
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
786
01:29Inflammatory Bowel Disease IV: Pharmacological Management
439
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
439
01:29Drugs for Treatment of Ulcerative Colitis in IBD
416
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
416